Filing Flows › Integra Lifesciences Holdings (IART) › Free cash flow
Integra Lifesciences Holdings (IART) free cash flow by quarter
Integra Lifesciences Holdings' free cash flow was $85.7M in Q3 2026 (third quarter 2026), +717% from Q2 2026. Over the last 3 quarters it ranged from $10.5M (Q2 2026) to $85.7M (Q3 2026).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $85.7M | +717% | +233% |
| Q2 2026 | $10.5M | -59% | — |
| Q3 2025 | $25.8M | — | — |
Q3 2026 at a glance
Integra Lifesciences Holdings, Q3 2026: revenue $411M (+2% year over year), operating margin 4.6%, net earnings $14.9M, operating cash flow $96.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is Integra Lifesciences Holdings' free cash flow?
Integra Lifesciences Holdings' free cash flow was $85.7M in Q3 2026 (third quarter 2026), +717% from Q2 2026.
How has Integra Lifesciences Holdings' free cash flow changed?
Over the last 3 quarters it ranged from $10.5M (Q2 2026) to $85.7M (Q3 2026).
Q3 2026 results → · How Integra Lifesciences Holdings makes money →